Mentors

Profile
Profile

MR. ANDRE MARQUIS

Executive Director Lester Center for Entrepreneurship @ UC Berkeley

Andre Marquis is the CEO of Hypershift Systems and Founder of the Innovation Acceleration Group at the at the University of California Berkeley. He was, most recently, Executive Director of the Lester Center for Entrepreneurship. He and his teams have built a scalable, global business process that delivers fundable startups and breakthrough product and service innovations for corporations by combining hypothesis-driven business model testing methods (acceleration) with hands-on training (education).

This Hypershift methodology has scaled to support rigorously testing hundreds of business model innovations per year and delivered breakthrough results to >1,200 teams. Real innovation has a high failure rate and requires testing lots of opportunities (scale) and testing them rigorously (intensity). This process delivers all four: education+acceleration+scale+intensity. Examples include the BOSCH global business model innovation accelerator (>70 teams/year), reality TV show America's Greatest Makers, Bay Area NSF Innovation Corps, Innovate for Digital India, Berkeley LAUNCH Startup Accelerator (2017 teams already raised over $10m) and other programs delivered in dozens of countries for governments, universities and companies including Intel, HP, BOSCH, Caterpillar, .... His team has redefined how to teach the process of evidence-based entrepreneurship and corporate innovation while creating funded, scalable enterprises and driving deep culture change simultaneously.

Mr Marquis has a long record of successful startups with a particular focus on winning in markets where scalability is critical. Two web companies Mr Marquis helped start became publicly traded and a third was acquired by Amazon for over $190 million. The Chorus Group at Eli Lilly which he co-founded is a significant corporate lean business model innovation that dramatically speeds up and lowered the cost of drug development and his most recent startup, Amplyx Pharmaceuticals, has raised $198m in funding.

Testimonials